Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02165839 · ClinicalTrials.gov registry record · NA
Brief Behavioral Intervention for Insomnia During Chemotherapy
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 139
- Enrollment target
NCT02165839: Completed NA study, sponsored by Stanford University.
NCT02165839 is a NA study that has completed, run by Stanford University. The registered enrollment target is 139 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02165839, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
Study Summary
PRIMARY OBJECTIVE(S): To evaluate the efficacy of the Brief Behavioral Therapy for Insomnia (BBT-I) in treating insomnia among breast cancer patients receiving chemotherapy. SECONDARY OBJECTIVE(S): * To evaluate the efficacy of the BBT-I in treating cancer-related symptoms such as cancer-related fatigue and cognitive difficulties in breast cancer patients receiving chemotherapy. * To examine potential moderators and mediators of BBT-I intervention effects on insomnia, cognitive difficulties, and fatigue. In particular, we are interested in age, depression and anxiety and side effects (hot flashes) as potential moderators of the intervention effects as well as evaluating modifiable behavioral and physiological mechanisms as hypothesized mediators
Interventions
- BEHAVIORAL Brief Behavioral Therapy for Insomnia (BBT-I)
- BEHAVIORAL Healthy Eating Education Learning (HEAL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2015-01 |
| Est. Completion | 2020-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02165839
The ClinicalTrials.gov registry entry for NCT02165839 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Brief Behavioral Therapy for Insomnia (BBT-I) is the first listed.
NCT02165839 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02165839 about?
NCT02165839 is a clinical study titled "Brief Behavioral Intervention for Insomnia During Chemotherapy". PRIMARY OBJECTIVE(S): To evaluate the efficacy of the Brief Behavioral Therapy for Insomnia (BBT-I) in treating insomnia among breast cancer patients receiving chemotherapy. SECONDARY OBJECTIVE(S): * To evaluate the efficacy of the BBT-I in treating cancer-related symptoms such as cancer-related ...
What is the current status of trial NCT02165839?
This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2015-01. Estimated completion is 2020-06.
What interventions are being tested in trial NCT02165839?
The interventions under investigation include: Brief Behavioral Therapy for Insomnia (BBT-I) (BEHAVIORAL), Healthy Eating Education Learning (HEAL) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02165839?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.